We are live on ! Find out more
TBIO

Telesis Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 27th of September, 2024.

Back to rankings

40 hedge funds and large institutions have $139M invested in Telesis Bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+40
Holders Change %
–
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
40
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$14M
2
TCM
TimesSquare Capital Management
New York
+$12.7M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$11.6M
4
Franklin Resources
Franklin Resources
California
+$10.8M
5
SAM
Sectoral Asset Management
Quebec, Canada
+$10.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$15.7M +$14M +39,715 New
TCM
2
TimesSquare Capital Management
New York
$14.2M +$12.7M +35,928 New
ACH
3
ArrowMark Colorado Holdings
Colorado
$13M +$11.6M +32,793 New
Franklin Resources
4
Franklin Resources
California
$12.1M +$10.8M +30,511 New
SAM
5
Sectoral Asset Management
Quebec, Canada
$11.4M +$10.1M +28,684 New
WP
6
Woodline Partners
California
$10.9M +$9.7M +27,439 New
PA
7
Perceptive Advisors
New York
$9.35M +$8.35M +23,611 New
PVI
8
Pura Vida Investments
New York
$8.8M +$7.86M +22,222 New
MWNA
9
Marshall Wace North America
New York
$5.16M +$4.6M +13,023 New
AC
10
Armistice Capital
New York
$4.4M +$3.93M +11,111 New
MIM
11
Monashee Investment Management
Massachusetts
$4.4M +$3.93M +11,111 New
RI
12
RTW Investments
New York
$4.4M +$3.93M +11,111 New
BlackRock
13
BlackRock
New York
$4.4M +$3.93M +11,109 New
FAM
14
Fred Alger Management
New York
$3.51M +$3.13M +8,854 New
Alyeska Investment Group
15
Alyeska Investment Group
Illinois
$2.2M +$1.96M +5,556 New
MS
16
Maven Securities
Jersey
$2.12M +$2.22M +6,276 New
Goldman Sachs
17
Goldman Sachs
New York
$1.47M +$1.31M +3,706 New
Citadel Advisors
18
Citadel Advisors
Florida
$1.37M +$1.22M +3,453 New
Point72 Asset Management
19
Point72 Asset Management
Connecticut
$1.1M +$982K +2,778 New
Tudor Investment Corp
20
Tudor Investment Corp
Connecticut
$1.1M +$982K +2,778 New
Vanguard Group
21
Vanguard Group
Pennsylvania
$1.1M +$982K +2,778 New
Federated Hermes
22
Federated Hermes
Pennsylvania
$990K +$884K +2,500 New
CCM
23
CAAS Capital Management
New York
$770K +$687K +1,944 New
GTC
24
Ghost Tree Capital
New York
$770K +$687K +1,944 New
LP
25
LMR Partners
United Kingdom
$733K +$654K +1,850 New
1
2

TBIO Hedge Fund Activity: Q2 2021 in Review

40 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Telesis Bio, Inc. Common Stock (TBIO) for Q2 2021, worth a combined $139M.

Buyers outnumbered sellers: 40 funds opened new TBIO positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $14M.

  • 40 institutional investors held Telesis Bio, Inc. Common Stock (TBIO) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $139M of Telesis Bio, Inc. Common Stock stock for Q2 2021.
  • 40 funds opened new Telesis Bio, Inc. Common Stock positions in Q2 2021 and 0 closed out, a net change of +40 holders.
  • The largest Telesis Bio, Inc. Common Stock buyer in Q2 2021 was Millennium Management, an estimated $14M added.

Based on aggregated 13F filings for Q2 2021.